Effectiveness of Injii chooranam Along with Vathakesari thylam For Balavatham in children

An open non randomized single Arm single centric clinical Trial to evaluate the Effectiveness of Inji Chooranam(Internal) and Vathakesari thylam(external) in the management of Balavatham in Children - Balavatham,Inji chooranam,

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/053514

Enrollment

Registered

2023-06-05

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: G00-G99- Diseases of the nervous system

Interventions

Intervention1: INJI CHOORANAM(INTERNAL) VATHAKESARI THYLAM(EXTERNAL): INTERNAL MEDICINE:Frequency: Twice a day Adjuvant: hot water, Dosage:3-4years - 375 mg 5-7 years - 552 mg 8-12 years -750 mg Durat

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of age group 3-12 years 2. Weakness of one or more limbs 3. Loss of power and tone in muscles of the affected limb 4. Difficulty/ Inability in using the affected limb against gravity and resistance 5. Difficulty in using the affected limb

Exclusion criteria

Exclusion criteria: 1.H/O Epilepsy 2.H/O Severe Aggressiveness with ADHD 3.H/O Autism 4.H/O Cerebral palsy 5.H/O Congenital Heart Disease 6.H/O Any other serious illness

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of Siddha regimen Inji chooranam (Internal) and Vathakesari Thylam (External) is measured by Modified aswarth scale for the management of Balavatham in children.Timepoint: 7 days once	—

Secondary

Measure	Time frame
1. To standardize the physicochemical properties of the trial drugs as per PLIM guidelines. 2. Reduction in the recurrence of clinical symptoms Timepoint: 7 days once	—

Countries

India

Contacts

Public ContactDrEElaveni

National Institute Of Siddha

mmssiddha@rediffmail.com9444214582

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026